Greece Drug Report 2017
Greece
Country Drug Report 2017
About this report
At a glance
NB: Data presented here are either national estimates (prevalence of use, opioid drug users) or reported numbers through the EMCDDA indicators (treatment clients, syringes, deaths and HIV diagnosis, drug law offences and seizures). Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.
Sections
What are the long-term aims of drug policy in Greece? How are these aims to be achieved? How is drug policy coordinated at national level?
Learn moreUnderstanding the costs of drug-related actions is an important aspect of policy evaluation.
Learn moreWhat substances and activities does Greece control under its drug laws? What are the penalties for offences? How are new psychoactive substances controlled?
Learn moreHow many people in Greece have ever used drugs? What drugs have they used? How many have used drugs recently? How many are using drugs in highly risky ways?
Learn moreWhat are the main infectious diseases linked to drug injecting in Greece? How many died of drug overdose in the last year? How many drug-related medical emergencies occurred?
Learn moreWhat part does prevention play in Greece drug strategy. What are the main prevention approaches used in the country and who do they target?
Learn moreHow does the Greece measure in terms of provision of needle and syringe programmes, peer naloxone programmes, supervised drug consumption rooms and heroin-assisted treatment.
Learn moreHow is the drug treatment system organised in Greece? How is it financed? How is the provision of treatment divided between inpatient and outpatient settings?
Learn moreWhich authorities are responsible for prison health in Greece? What forms of drug treatment and harm reduction are provided in prisons, and how widely?
Learn moreWhat is done in Greece to ensure that the prevention and treatment interventions used are effective and provide a good return on public expenditure?
Learn moreIn which areas of study is drug-related research carried out in Greece? How is this research funded? Are any types of research emphasised in the national drug strategy?
Learn moreWhat is known about drug supply and trafficking in the Greece? How pure or strong are the drugs available? What do they cost? What are the main aims of supply reduction efforts?
Learn morePartners
About our partner in Greece
The Greek national focal point is located within the University Mental Health Research Institute and operates as the National Centre of Documentation and Information on Drugs. The national focal point operates on the basis of a three-year contract with the Ministry of Health and collaborates with OKANA (the Greek Organisation Against Drugs). Overall, the national focal point deals with drug-related issues in the field of epidemiology and responses, and is given a mandate beyond the implementation of EMCDDA-related activities. Its responsibilities also include monitoring alcohol use and related problems, and drafting the Greek National report on drugs, the annual Greek bibliography on drugs and alcohol, and other alcohol-related assignments.
University Mental Health Research Institute
Soranou tou Efesiou, 2
(PO Box 66 517)
GR-15601 Athens
Greece
Tel. +30 2106536902
Fax +30 2106537273
Head of national focal point: Ms Manina Terzidou